Afuco™ Anti-HBV ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-746) (CAT#: AFC-TAB-746)
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human monoclonal antibody expressed in CHO binding to HBV. It is a human monoclonal antibody developed for the treatment of hepatitis B infections.
Specific Inquiry
Custom Production
We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.
We require custom production
Specifications
- Immunogen
- The details of the immunogen for this antibody are not available.
- Host Species
- Human
- Derivation
- Human
- Type
- ADCC enhanced antibody
- Species Reactivity
- HBV
- Applications
- FC, IP, ELISA, Neut, FuncS, IF
- Conjugate
- Unconjugated
- Trade name
- Hepex-B
- Generic Name
- Exbivirumab
- Related Disease
- Hepatitis B reinfection in liver transplant patients
Product Property
- Purity
- >95% by SDS-PAGE
- Storage
- Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Target
- Alternative Names
- HBV; Major surface antigen
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "exbivirumab"
Anti-HBV Recombinant Antibody (Exbivirumab)Recombinant human monoclonal antibody expressed in CHO binding to HBV. Exbivirumab is a human monoclonal antibody developed for the treatment of hepatitis B infections.
DrugMonitor™ Anti-Exbivirumab Antibody (VS-1224-YC461)Exbivirumab is an investigational monoclonal antibody used in HepeX-B, a drug containing two human monoclonal antibodies targeting the hepatitis B virus (HBV) surface antigen. The DrugMonitor™ Anti-Exbivirumab Antibody (VS-1224-YC461) is an anti-drug antibody (ADA) against Exbivirumab. This drug-based antibody is raised in mice immunized with the Exbivirumab. The anti-Exbivirumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Exbivirumab in samples.
See other products for "HBV"
Select a product category from the dropdown menu below to view related products.
Please select product type
Single Domain Antibodies
Human Antibodies
Humanized Antibodies
Mouse Antibodies
MHC Tetramers for Virology
ScFv Antibodies
Fab Antibodies
ADCC Enhanced Antibodies
IgG Antibodies
ScFv-Fc Chimeras
| CAT | Product Name | Application | Type |
|---|---|---|---|
| NAB-1234-sdAb | Recombinant Anti-HBV VHH Single Domain Antibody | IHC, IP, FC, Neut, FUNC | Llama VHH |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for AFC-TAB-746. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: ELISA, Neut, IF, IP, FC, FuncS
Application: FC, IP, ELISA, Neut, FuncS, IF, WB
Application: IP, IF, FuncS, FC, Neut, ELISA, ICC
Application: SPR, Inhib, FuncS
Application: ELISA, FuncS
-3.jpg)
Application: Neut
Application: ELISA, Neut
For Research Use Only. Not For Clinical Use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
